NO934726L - (S) (+) - 2-ethoxy-4- (N- (1- (2-piperidinophenyl) -3-methyl-1-butyl) aminocarbonylmethyl) -benzoic - Google Patents

(S) (+) - 2-ethoxy-4- (N- (1- (2-piperidinophenyl) -3-methyl-1-butyl) aminocarbonylmethyl) -benzoic

Info

Publication number
NO934726L
NO934726L NO934726A NO934726A NO934726L NO 934726 L NO934726 L NO 934726L NO 934726 A NO934726 A NO 934726A NO 934726 A NO934726 A NO 934726A NO 934726 L NO934726 L NO 934726L
Authority
NO
Norway
Prior art keywords
piperidinophenyl
aminocarbonylmethyl
benzoic
ethoxy
butyl
Prior art date
Application number
NO934726A
Other languages
Norwegian (no)
Other versions
NO303687B1 (en
NO934726D0 (en
Inventor
Wolfgang Grell
Andreas Greischel
Gabriele Zahn
Michael Mark
Hansjoerg Knorr
Eckhard Rupprecht
Uelrich Mueller
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36781542&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO934726(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CA002111851A external-priority patent/CA2111851C/en
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO934726L publication Critical patent/NO934726L/en
Publication of NO934726D0 publication Critical patent/NO934726D0/en
Publication of NO303687B1 publication Critical patent/NO303687B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO934726A 1991-06-21 1993-12-20 Analogous process for the preparation of the therapeutically active compound (S) (+) - 2-ethoxy-4- [N- [1- (2-piperidino-phenyl) -3-methyl-1-butyl] aminocarbonylmethyl] -benzoic acid NO303687B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SG1996002715A SG43036A1 (en) 1991-06-21 1991-06-21 (S) (+) -2-ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl- 1-buthyl]aminocarbony methyl] - benzoic a cid
PCT/EP1991/001147 WO1993000337A1 (en) 1991-06-21 1991-06-21 (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
CA002111851A CA2111851C (en) 1991-06-21 1991-06-21 (s)(+)-2-ethoxy-4-[n-{1-(2-piperidino-phenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
CN91104984A CN1048722C (en) 1991-06-21 1991-07-22 (S)(+)-2-Ethoxy-4-[N-[1-(2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbonylmethyl]-benzoic acid, pharmaceutical compositions containing compound and processes for preparation thereof

Publications (3)

Publication Number Publication Date
NO934726L true NO934726L (en) 1993-12-20
NO934726D0 NO934726D0 (en) 1993-12-20
NO303687B1 NO303687B1 (en) 1998-08-17

Family

ID=36781542

Family Applications (2)

Application Number Title Priority Date Filing Date
NO934726A NO303687B1 (en) 1991-06-21 1993-12-20 Analogous process for the preparation of the therapeutically active compound (S) (+) - 2-ethoxy-4- [N- [1- (2-piperidino-phenyl) -3-methyl-1-butyl] aminocarbonylmethyl] -benzoic acid
NO1999017C NO1999017I1 (en) 1991-06-21 1999-07-20 Repaglinide

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO1999017C NO1999017I1 (en) 1991-06-21 1999-07-20 Repaglinide

Country Status (8)

Country Link
EP (1) EP0589874B1 (en)
JP (1) JP2921982B2 (en)
CN (1) CN1048722C (en)
AU (1) AU660930B2 (en)
FI (1) FI106027B (en)
NO (2) NO303687B1 (en)
SG (1) SG43036A1 (en)
WO (1) WO1993000337A1 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998056378A1 (en) 1997-06-13 1998-12-17 Novo Nordisk A/S Novel niddm regimen
IN192862B (en) 1999-11-16 2004-05-22 Ranbaxy Lab Ltd
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
PE20020617A1 (en) 2000-08-22 2002-08-05 Novartis Ag COMPOSITION INCLUDING AN AT1 RECEPTOR ANTAGONIST AND AN INSULIN SECRETION POTENTIAL OR AN INSULIN SENSITIZER
WO2004018442A1 (en) * 2002-08-23 2004-03-04 Dr. Reddy's Laboratories Limited Crystalline and amorphous forms of (s) -repaglinide and the processes for preparation thereof
EP1636199A2 (en) * 2003-05-14 2006-03-22 Cilag AG Method for the production of phenylacetic acid derivatives
WO2004103983A1 (en) * 2003-05-26 2004-12-02 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives
WO2005021524A1 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Process for the preparation of amorphous form of repaglinide
CN1305863C (en) * 2004-12-27 2007-03-21 浙江大学 Method for synthesizing (S)-isopropyl-(2-piperidine) phenyl-methylhistamine
GT200600381A (en) 2005-08-25 2007-03-28 ORGANIC COMPOUNDS
FR2898894B1 (en) * 2006-03-24 2008-06-06 Genfit Sa SUBSTITUTED N- (PHENETHYL) BENZAMIDE DERIVATIVE COMPOUNDS, PREPARATION AND USES
US7763607B2 (en) * 2006-04-27 2010-07-27 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators
SI2724722T1 (en) * 2006-10-20 2017-07-31 Neurendo Pharma, Llc Method of restoring the incretin effect
US8101769B2 (en) 2007-02-15 2012-01-24 Actavis Group Ptc Ehf Process for preparing ethyl (S)-2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonyl methyl]benzoate and use thereof for the preparation of Repaglinide
EP2155706A2 (en) * 2007-06-06 2010-02-24 Actavis Group PTC EHF Repaglinide substantially free of dimer impurity
EP2019097A1 (en) 2007-07-25 2009-01-28 Aurobindo Pharma Limited Process for preparing (alphaS)-alpha-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine
DE102008046995B4 (en) * 2008-09-12 2010-08-26 Stada Arzneimittel Ag 2-ethoxy-benzoic acid
EP2177221A1 (en) 2008-10-20 2010-04-21 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of substantially optically pure Repaglinide and precursors thereof
ES2430088T3 (en) 2009-05-15 2013-11-18 Novartis Ag Benzoxazolone derivatives as aldosterone synthase inhibitors
AU2010247414B2 (en) 2009-05-15 2013-08-01 Novartis Ag Aryl pyridine as aldosterone synthase inhibitors
EP2594557B1 (en) 2009-05-28 2016-08-10 Novartis AG Substituted aminopropionic derivatives as neprilysin inhibitors
MX2011012627A (en) 2009-05-28 2011-12-14 Novartis Ag Substituted aminobutyric derivatives as neprilysin inhibitors.
ES2663351T3 (en) 2009-11-17 2018-04-12 Novartis Ag Aryl-pyridine derivatives as aldosterone synthase inhibitors
JO2967B1 (en) 2009-11-20 2016-03-15 نوفارتس ايه جي Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
EP2507234B1 (en) 2009-11-30 2014-03-12 Novartis AG Imidazole derivatives as aldosterone synthase inhibitors
EP2364977A1 (en) 2010-01-26 2011-09-14 Reuter Chemische Apparatebau KG Process for the enantiomeric enrichment of 3-methyl-1-(2-piperidinophenyl)-1-butylamine
US8673974B2 (en) 2010-11-16 2014-03-18 Novartis Ag Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
CN102267959B (en) * 2011-07-06 2013-05-01 海南锦瑞制药股份有限公司 Repaglinide crystal, preparation method thereof, and solid oral preparation containing same
CN103012319B (en) * 2011-09-20 2015-06-10 浙江九洲药业股份有限公司 Repaglinide intermediate synthesis process improvement
CN102584743A (en) * 2011-12-28 2012-07-18 中国药科大学 Dimethylaminopyridine repaglinide eutectic
UY35144A (en) 2012-11-20 2014-06-30 Novartis Ag APELINE SYNTHETIC LINEAR MIMETICS FOR THE CARDIAC INSUFFICIENCY TREATMENT
CN105073762B (en) 2013-02-14 2017-03-08 诺华股份有限公司 Substituted biphenyl butyryl phosphonate derivative as NEP (neutral endopeptidase) inhibitor
EP3024845A1 (en) 2013-07-25 2016-06-01 Novartis AG Cyclic polypeptides for the treatment of heart failure
UY35671A (en) 2013-07-25 2015-02-27 Novartis Ag SYNTHETIC APELINE POLYPEPTIDE BIOCONJUGATES
CN107405343A (en) 2014-11-07 2017-11-28 明尼苏达大学董事会 Salt and composition available for treatment disease
SG11201704758XA (en) 2015-01-23 2017-08-30 Novartis Ag Synthetic apelin fatty acid conjugates with improved half-life
WO2018034627A1 (en) 2016-08-18 2018-02-22 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Pharmaceutical composition of antidiabetic tablet
UY38072A (en) 2018-02-07 2019-10-01 Novartis Ag COMPOSITIONS DERIVED FROM BUTANOIC ESTER SUBSTITUTED WITH BISPHENYL AS INHIBITORS OF NEP, COMPOSITIONS AND COMBINATIONS OF THE SAME

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3347565A1 (en) * 1983-12-30 1985-07-11 Thomae Gmbh Dr K NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF

Also Published As

Publication number Publication date
AU660930B2 (en) 1995-07-13
CN1048722C (en) 2000-01-26
FI935724A (en) 1993-12-20
CN1068820A (en) 1993-02-10
WO1993000337A1 (en) 1993-01-07
EP0589874B1 (en) 1999-09-08
JP2921982B2 (en) 1999-07-19
NO303687B1 (en) 1998-08-17
NO1999017I1 (en) 1999-07-20
EP0589874A1 (en) 1994-04-06
JPH06508816A (en) 1994-10-06
NO934726D0 (en) 1993-12-20
SG43036A1 (en) 1997-10-17
FI106027B (en) 2000-11-15
FI935724A0 (en) 1993-12-20
AU8078191A (en) 1993-01-25

Similar Documents

Publication Publication Date Title
NO934726L (en) (S) (+) - 2-ethoxy-4- (N- (1- (2-piperidinophenyl) -3-methyl-1-butyl) aminocarbonylmethyl) -benzoic
NO921451D0 (en) Heterocyclic Amides
FI925383A0 (en) ARRANGEMANG FOER ATT ERHAOLLA NYCKELPARAMETRAR FOER BESTYRKNING I CELLULAERT MOBILTELEFONINAET
DE69228473T2 (en) MEDIA
DK0506202T4 (en) Etiquette
DE9218590U1 (en) Tape printer
DE69429147D1 (en) benzamide derivatives
DE69425947D1 (en) Tape printer
FI933990A (en) ANORDNING FOER ATT TILLVERKA EN TORKAD PAPPERSBANA
NO920157D0 (en) HETEROCYCLIC HYDROXYLAMINES
FI945086A0 (en) 1- (2H-1-benzopyran-2-one-8-yl) piperazine
NO922199D0 (en) FIXABLE PORTABLE MINI-SAFE
DE69430613T2 (en) Tape printing device
DE69207560T2 (en) Antidiabetic
DE69212286D1 (en) Cooler
NO924464D0 (en) DATA DEKOERINGSANORDNING
NO924465L (en) KINOLYLMETOKSYFENYL-acetic acid amide
DE69430470T2 (en) Tape printing device
ITMI922402A0 (en) TACTICAL HEADBOARD
FI921131A (en) FOERFARANDE FOER ATT REALISERA INBINDNINGSELEMENT
DE9319875U1 (en) Anesthesia set
DE9218594U1 (en) Tape printer
KR950009791U (en) VTR trouble check device
BR7102857U (en) PORTABLE SIRENE
BR9105102A (en) PORTABLE CHAFARIZ

Legal Events

Date Code Title Description
SPCG Granted supplementary protection certificate

Free format text: PRODUCT NAME: REPAGLINID; NAT. REG. NO/DATE: NO , 97-2543 , NO , 97-2544 , NO , 97-2545 19990301; FIRST REG. NO/DATE: EP , 1/98/076/- 19980817

Spc suppl protection certif: 1999017

Filing date: 19990720

Extension date: 20130817

MK1K Patent expired
SPCX Expiry of an spc

Spc suppl protection certif: 1999017

Effective date: 20130817